When One Person Holds Up Progress: Why Structured Consultants Become Long-Term Partners

In every transition or carve-out, the success of the project depends on more than just the playbooks and timelines—it depends on the people at the table. Even the best-designed process can stall when a single individual creates roadblocks, delays decisions, or resists collaboration.
We’ve all seen it. A project that should move quickly suddenly slows down. A bottleneck forms because one person refuses to align, or simply lacks the structure and discipline required to manage complexity. Procurement and contract transitions, in particular, are highly vulnerable—where every week of delay translates into higher costs, missed savings, and frustrated stakeholders.
Why People Matter as Much as Process
That’s why the type of people executing a transition is just as important as the process itself. A structured, professional consultant brings something critical: the ability to cut through noise, keep the team aligned, and drive steady progress no matter how challenging the dynamics may be. Over time, this professionalism and consistency build trust—not only with the client’s executives, but also with the portfolio companies who experience the difference firsthand.
Jim Collins, in his classic book Good to Great, wrote about “getting the right people on the bus.” The same lesson applies in M&A transitions. The right people don’t just execute tasks—they set the tone for collaboration, bring clarity where there is uncertainty, and keep momentum when others hesitate. The wrong person, even if technically capable, can hold up an entire project.
Lessons from the Field: Big Firms vs. Boutique Specialists
Large consulting firms know this too. Bain & Company, for example, often emphasizes putting A-players on integration teams because they understand that speed and structure are as valuable as strategy.
Accenture offers another instructive case. On a complex carve-out, they stepped in with structured program managers who brought clarity and order where one internal stakeholder had been creating delays. The difference was immediate, momentum picked back up, milestones were met, and the client took notice. That structured approach earned Accenture more business in the long run, while the individual who had been blocking progress quietly exited. The lesson was clear: structured consultants create efficiency, and inefficiency eventually eliminates itself.
Boutique firms like In2edge deliver the same level of structure and execution discipline—but without the unnecessary cost or bureaucracy. That’s why private equity sponsors increasingly look to specialists who know how to move fast, scale resources up or down, and adapt to the dynamics of a live deal.
The Long-Term Payoff
At In2edge, we’ve seen it repeatedly: structured consultants who combine expertise with process discipline become the long-term partners our clients turn to deal after deal. Because when you have the right team in place, efficiency goes up, cost goes down, and results follow naturally.
It’s a reminder that in carve-outs and transitions, you don’t just need someone in the seat. You need the right person—someone who brings clarity instead of chaos, structure instead of delays, and partnership instead of politics.







In the complex and high-stakes realm of mergers and acquisitions (M&A), the devil truly lies in the details—specifically, within the dense text of contracts. The tale of the Columbus acquisition serves as a stark reminder of this truth, where excitement and oversight led to a staggering $75 million loss, all due to neglected customer agreements with burdensome rebates and unfavorable pricing terms. This incident underscores a crucial lesson: comprehensive contract due diligence is not just beneficial; it’s essential.
In the complex landscape of mergers and acquisitions (M&A) within highly regulated industries, the importance of compliance, risk mitigation, and cybersecurity cannot be overstated. These critical elements act as the pillars supporting a successful transition process, safeguarding against potential legal, financial, and reputational damages.
In the world of business, contract management is often visualized as a journey where the path from initiation to conclusion is not just a timeline but a value-generating process. As contracts progress over time, their potential to add value increases with diligent management. However, during mergers and acquisitions (M&A), this timeline is compressed, necessitating swift and strategic actions to extract maximum value and ensure a smooth transition.
In the high-stakes world of pharmaceutical divestitures, mergers and acquisitions (M&A), the due diligence and contract transition phases are pivotal. These stages are filled with unique challenges and nuances that can significantly impact the success of an acquisition or divestiture. Understanding these nuances is essential for navigating the pharmaceutical landscape effectively and ensuring a smooth transition and integration of assets.

